Troxerutin

Belcaro G, Cesarone MR, Bavera P, Ricci A, et al.
HR (Venoruton1000, Paroven, 0-[beta-hydroxyethyl]-rutosides) vs. Daflon 500 in chronic venous disease and microangiopathy: an independent prospective, controlled, randomized trial.

http://www.ncbi.nlm.nih.gov

Cesarone MR. et al
HR, 0-(beta-hydroxyethyl)-rutosides; (Venoruton): rapid relief of signs/symptoms in chronic venous insufficiency and microangiopathy: a prospective, controlled study.

http://www.ncbi.nlm.nih.gov

Glacet-Bernard A, Coscas G, Chabanel A, Zourdani A, Lelong F, Samama MM.
A randomized, double-masked study on the treatment of retinal vein occlusion with troxerutin.

http://www.ncbi.nlm.nih.gov

Petruzzellis V, Troccoli T, Candiani C, Guarisco R, et al.
Oxerutins (Venoruton): efficacy in chronic venous insufficiency--a double-blind, randomized, controlled study.

http://www.ncbi.nlm.nih.gov

INTERPHARMA PRAHA, a.s., Komoranska 955, 143 10 Praha 12, Czech Republic

Business Development: 00420-241 773 242

Secretariat: 00420-241 773 242, Fax: 00420-241 773 235

 

Email: